Vimarsana
Biggest News Aggregation in the World

Page 2 - Mark Harber News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Harber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Harber Today - Breaking & Trending Today

Letters: Today's celebrity 'guest editors' are an insult to hard-working BBC staff - Vimarsana News

Letters: Today's celebrity 'guest editors' are an insult to hard-working BBC staff

SIR – I spent nearly 30 years at the BBC, mainly in an editorial role in the radio newsroom – which included the night we joined the Common Market – later on Today, Radio 1, Radio 4 and in news management.

Takeda UK Ltd: NICE recommends LIVTENCITY? (maribavir) for the treatment of adults with post-transplant cytomegalovirus (CMV) refractory (with or without resistance) to prior therapies - Vimarsana News

Takeda UK Ltd: NICE recommends LIVTENCITY? (maribavir) for the treatment of adults with post-transplant cytomegalovirus (CMV) refractory (with or without resistance) to prior therapies

Takeda UK Ltd. is pleased to announce that NICE has recommended the use of LIVTENCITY? (maribavir) as a twice daily oral treatment for adult patients with post-transplant cytomegalovirus (CMV)

Blood Test for Kidney Rejection Suggests New Treatment - Vimarsana News

Blood Test for Kidney Rejection Suggests New Treatment

Date Time Blood Test for Kidney Rejection Suggests New Treatment PITTSBURGH– Researchers at the University of Pittsburgh School of Medicine have discovered a blood biomarker that predicts kidney transplant rejection with a lead time of about eight months, which could give doctors an opportunity to intervene and prevent permanent damage. These results, published today in Science Translational Medicine, not only identify a warning signal that something is going wrong, but also suggest an existing medication that could be given to these patients to right the course of their long-term recovery....

Blood test for kidney rejection suggests new way to treat post-transplant patients - Vimarsana News

Blood test for kidney rejection suggests new way to treat post-transplant patients

 E-Mail IMAGE: Pittsburgh Steelers Chair in Transplantation and professor of surgery, medicine and immunology, University of Pittsburgh School of Medicine view more  Credit: Thomas E. Starzl Transplantation Institute at the University of Pittsburgh PITTSBURGH, Feb. 24, 2021 - Researchers at the University of Pittsburgh School of Medicine have discovered a blood biomarker that predicts kidney transplant rejection with a lead time of about eight months, which could give doctors an opportunity to intervene and prevent permanent damage. These results, published today in Science Transl...